Dubai Final-v20.indd - World Allergy Organization

POstErs
WAO IntErnAtIOnAl ScIEntIfIc cOnfErEncE
Asthma and Co-morbid Conditions: Expanding the Practice of Allergy for Optimal Patient Care
Wednesday, 8 December 2010 – Poster Session 3
9:30 – 10:30 PO3-1: immune mechanisms of allergy sheikh rashid F
To view full abstracts from this session, please reference pages 139-145 of the ‘Abstracts’ section in this program.
Chairpersons: robert lemanske
Jung Wong Park
3100
an UnUSUal PrESEnTaTion oF PUlmonarY maSS liKE lESionS SEConDarY To an allErgiC CaUSE
m. rafique, Pulmonologist and B. mahboub, Head, of, Pulmonary, medicine
Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates.
3101
ForgoTTEn ParaSiTES in allErgY PraCTiCE
P. Kumar, mD
Medicine, Louisiana State University Health Sciences Center, New Orleans, LA.
3102
CHaraCTEriSTiCS oF rHinoVirUS-inDUCED PBmC immUnE rESPonSES in aSTHmaTiCS, From inFanCY To aDUlTHooD
i. Katsuhito 1 , t. Katsunuma 1 , H. saito, mD, PhD, Director 2 and K. matsumoto, mD, PhD, laboratory, Head 2
1 Pediatrics, Jikei University, school of medicine, Tokyo, Japan. 2 Laboratory for allergy, Department of Allergy and Immunology,
National Research Institute for Child Health and Development, Tokyo, Japan, Tokyo, Japan.
3103
CUrCUmin maY inHiBiTS T CEll aCTiVaTion THroUgH STorE-oPEraTED Ca2+ EnTrY CHannElS anD K+ CHannElS
W. K. Kim, Doctor1 and J. H. nam2 1 2 Asthma & Allergy, Dongguk University Ilsan Hospital, Goyang, South Korea. Physiology, Dongguk University collage of medicine,
Kyung Ju, South Korea.
3104
nano-SiZED WElDing FUmE inCrEaSES inFlammaTorY CYToKinES, aPoPToSiS anD g2 arrEST in HUman T CEll linE
Y. m. Chiung 1 , P. s. liu 2 , Y. Y. Chen 2 , J. B. lin 1 and C. J. tsai 3
1 Division of Medicine, Institute of Occupational Safety & Health, Taipei County, Taiwan. 2 Department of Microbiology, Soochow
University, Taipei, Taiwan. 3 Institute of Environmental Engineering, National Chiao Tung University, Hsinchu.
3105
THE EFFiCaCY oF a naSal anTiHiSTaminE oloPaTaDinE For THE TrEaTmEnT oF SEroUS oTiTiS mEDia in CHilDrEn
s. nsouli, m, D.
Asthma and Allergy, DANVILLE ASTHMA AND ALLERGY CLINIC, DANVILLE, CALIFORNIA, USA, Danville, CA.
3106
ComBinaTion oF a naSal anTiHiSTaminE oloPaTaDinE anD a naSal CorTiCoSTEroiD, momETaSonE For THE
TrEaTmEnT oF SEaSonal allErgiC rHiniTiS PaTiEnTS noT CUrrEnTlY ConTrollED on monoTHEraPY inTranaSal
anTiHiSTaminE or inTranaSal CorTiCoSTEroiD
s. nsouli, mD, AnD, sEniOr, CliniCAl, rEsEArCH, AssOCiAtE
Asthma and Allergy, DANVILLE ASTHMA AND ALLERGY CLINIC, CALIFORNIA, USA, Danville, CA.
3107
EXPErimEnTallY UnraVEling THE aToPiC marCH
m. s. Wilson, PhD
Molecular Immunology, NIMR, MRC, London, United Kingdom.
3108
a noVEl rolE For THE ComPlEmEnT rEgUlaTor CD46 in EPiTHElial TigHT JUnCTion FormaTion/rEgUlaTion
s. t. Al-shouli1 and C. Kemper2 1 2 Clinical Immunology and Allergy., King’s College London Guy’s and S’t Thomas’ Hospital, London, United Kingdom. MRC Centre for
Transplantation, London, United Kingdom.
www.worldallergy.org 71
FinAl PrOgrAm
POstErs